Hepatitis C virus (HCV) infection can lead to long-term health problems including liver damage, liver failure, cirrhosis, liver cancer and even death. These outcomes are especially dangerous for pregnant people and their ...
Oct 29, 2021
0
30
Researchers at the Medical University of South Carolina (MUSC) report in the Journal of Viral Hepatitis that the activity levels of the proteins involved in liver scarring, or cirrhosis, begin to decrease immediately after ...
Oct 26, 2021
0
5
Nineteen months into the pandemic, the need for antiviral drugs targeted against COVID-19 is clear, given the global persistence of the virus, its ability to rapidly mutate into new variants and the possibility that it could ...
Oct 22, 2021
0
14
Two scientists won the Nobel Prize in medicine on Monday for their discoveries into how the human body perceives temperature and touch, revelations that could lead to new ways of treating pain or even heart disease.
Oct 4, 2021
0
72
The development of direct-acting antiviral (DAA) agents revolutionized treatment for the hepatitis C virus (HCV) in 2013, changing the disease from one that can be controlled to one that can be cured. But with a list price ...
Sep 6, 2021
0
6
When the COVID-19 pandemic ripped through New England and the rest of the United States in early 2020, substance use disorder treatment centers were forced to make massive changes to minimize the spread of coronavirus.
Jul 21, 2021
0
4
Imagine it's 2030—and a typical day in a Nigerian healthcare setting. In earlier decades, when a patient walked in, they could see piles of folders and a clutter of pens scattered all over the office. They'd have a long ...
Jul 21, 2021
0
3
There's a good reason why hepatitis C is known as a "silent killer."
Jul 20, 2021
0
3
A vaccine to protect against infection with hepatitis C could be in use within 5 years, says Professor Sir Michael Houghton, who won the Nobel Prize for Medicine and Physiology along with three other scientists for discovering ...
Jul 12, 2021
0
11
(HealthDay)—Health care providers should test liver recipients for hepatitis B virus (HBV) given the slight risk for unexpected donor-derived HBV infection, according to research published in the July 9 issue of the U.S. ...
Jul 12, 2021
0
0
